Hadassah’s HIV/AIDS Experts Host Psychosocial Workshop in Addis Ababa for Orphanage Staff
Under the umbrella of the Hadassah Medical Organization’s ART-Joy-Love project in Ethiopia, Hadassah’s HIV/AIDS experts presented a four-day psychosocial workshop in Addis Ababa for the staff of five HIV/AIDS orphanages in January.
Based on years of clinical experience and educational outreach by Hadassah’s Pediatric AIDS multidisciplinary team, the workshop was facilitated by Estelle Rubinstein, Director of Hadassah’s Department of Social Work, Ahuva Yavin Arnon, a psychologist from its Pediatric Psychiatry Unit, and Prof. Dan Engelhard, head of Pediatric Infectious Diseases and the Pediatric AIDS Center at Hadassah.
Eighteen Ethiopian caregivers, including psychologists, social workers, and nurses, participated in the workshop. Collectively, they care for about 500 orphans.
With 500 beds, 19 stories (five underground) and state-of-the-art technical equipment, the Tower is the most advanced medical facility in the Middle East.
Emphasizing the pivotal importance of dealing with psychosocial issues in treating children and adolescent orphans who are living with HIV, the seminar addressed the ways in which caregivers can help the children to cope with their very difficult life stories and the stigma of HIV; how to disclose an HIV diagnosis to the children; methods of building self-esteem; strategies for sex education; and dealing with behavioral problems. The workshop also focused on the needs of the caregivers, themselves, offering ideas for preventing burnout in such an emotionally challenging work environment.
Israel’s Ambassador to Ethiopia, HE Belaynesh Zevadia, took part in one of the sessions. She conveyed her deep appreciation to the Ethiopian and Israeli teams for their commitment to these children.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>